Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship

Open Access 08-05-2024 | Colorectal Cancer

The psychosocial health of sexual and gender minority people with anal and colorectal cancer: a mixed methods study

Authors: Oscar Y. Franco-Rocha, Katie Trainum, Christopher W. Wheldon

Published in: Journal of Cancer Survivorship

Login to get access

Abstract

Purpose

Sexual and gender minority (SGM) cancer survivors have poorer psychosocial health than their heterosexual cisgender counterparts. Nevertheless, most research has focused on breast and prostate survivors. It is unknown how different gastrointestinal (GI) cancers affect the psychosocial well-being of SGM individuals. We (1) described the psychosocial health of SGM people with GI cancers and (2) identified differences in psychosocial health outcomes by cancer type.

Methods

We conducted a concurrent mixed-methods secondary analysis with identical samples (n = 295) using data from “OUT: The National Cancer Survey.” Likert-type and open-ended questions about demographics, satisfaction with care, social support, and access to mental health resources were included in the analysis. Poor mental health was the primary outcome. Quantitative (linear regression) and qualitative (thematic analysis) data were independently analyzed, then integrated through the narrative, weaving approach.

Results

Three concepts emerged after data integration, (1) positive and negative influences on the psychological well-being of the participants; (2) social adaptations with the participants’ friends, partners, and family members; and (3) additional factors affecting the psychosocial well-being during and after cancer, particularly interactions with providers, comorbidities, and treatment side effects.

Conclusion

Clinical characteristics, demographic factors, and culturally responsive care influenced the psychosocial health of SGM survivors of GI cancers.

Implications for Cancer Survivors

Participants developed their own coping strategies and advocated for the SGM community. Interventions promoting peer support and self-esteem are a priority for this population. Healthcare professional training should incorporate historical trauma awareness and assess the delivery of culturally responsive care.
Appendix
Available only for authorised users
Literature
1.
Agénor M. What are the numbers? The epidemiology of cancer by sexual orientation and gender identity. In: Boehmer U, Elk R, editors. Cancer LGBT Community. Switzerland: Springer International Publishing; 2016. pp. 117–40.
2.
Gonzales G, Zinone R. Cancer diagnoses among lesbian, gay, and bisexual adults: results from the 2013-2016 National Health Interview Survey. Cancer Causes Control. 2018;29:845–54.
3.
Smalley KB, Warren JC, Barefoot KN. Differences in health risk behaviors across understudied LGBT subgroups. Heal Psychol. 2016;35:103–14.CrossRef
4.
Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning populations (LGBTQ). CA Cancer J Clin. 2015;65:384–400.CrossRefPubMedPubMedCentral
5.
Matthews AK, Breen E, Kittiteerasack P. Social determinants of LGBT cancer health inequities. Semin Oncol Nurs. 2018;34:12–20.CrossRefPubMed
6.
Hafeez H, Zeshan M, Tahir MA, Jahan N, Naveed S. Health care disparities among lesbian, gay, bisexual, and transgender youth: a literature review. Cureus. 2017;9:e1184.
7.
Zaritsky E, Dibble SL. Risk factors for reproductive and breast cancers among older lesbians. J Womens Health (Larchmt). United States. 2010;19:125–31.
8.
9.
Whitehead J, Shaver J, Stephenson R. Outness, stigma, and primary health care utilization among rural LGBT populations. PLoS ONE. 2016;11:1–17.CrossRef
10.
Franco-Rocha OY, Wheldon CW, Osier N, Lett E, Kesler SR, Henneghan AM, et al. Cisheteronormativity and its influence on the psychosocial experience of LGBTQ+ people with cancer: a qualitative systematic review. Psychooncology. 2023;32:834–45.CrossRefPubMed
11.
Schefter A, Thomaier L, Jewett P, Brown K, Stenzel AE, Blaes A, et al. Cross-sectional study of psychosocial well-being among lesbian, gay, bisexual, and heterosexual gynecologic cancer survivors. Cancer Rep (Hoboken). 2022;5:e1461.
12.
Franco-Rocha OY, Wheldon CW, Trainum K, Kesler SR, Henneghan AM. Clinical, psychosocial, and sociodemographic factors that may influence cognitive functioning in sexual and gender minority groups with cancer: a systematic review. Eur J Oncol Nurs. 2023;64:102343.CrossRefPubMed
13.
Boehmer U, Ozonoff A, Winter M, Berklein F, Potter J, Ceballos RM, et al. Anxiety and depression in colorectal cancer survivors: are there differences by sexual orientation? Psychooncology. 2022;31:521–31.
14.
Boehmer U, Ozonoff A, Winter M, Berklein F, Potter J, Hartshorn KL, et al. Health-related quality of life among colorectal cancer survivors of diverse sexual orientations. Cancer. 2021;127:3847–55.
15.
Boehmer U, Clark MA, Winter M, Berklein F, Ozonoff A. Sexual minority-specific experiences of colorectal cancer survivors. Heal Psychol. 2022;41:884–92.
16.
Baughman A, Clark MA, Boehmer U. Experiences and concerns of lesbian, gay, or bisexual individuals with colorectal cancer. Oncol Nurs Forum. 2017;44:350–7.CrossRefPubMedPubMedCentral
17.
Mauro GP, da Conceição Vasconcelos KGM, Carvalho H de A. Quality of life and sexual function of men who have sex with men treated for anal cancer: a prospective trial of a neglected population. J Sex Med. 2021;18:1461–6.
18.
Collins KMT, Onwuegbuzie AJ, Jiao QG. A mixed methods investigation of mixed methods sampling designs in social and health science research. J Mix Methods Res. 2007;1:267–94.
19.
Bazeley P. Integrating analyses in mixed methods research. London: SAGE Publications Ltd; 2018.
20.
Wasti SP, Simkhada P, van Teijlingen ER, Sathian B, Banerjee I. The growing importance of mixed-methods research in health. Nepal J Epidemiol. 2022;12:1175–8.
21.
22.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
23.
Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48:2134–56.
24.
Guetterman TC, Fetters MD, Creswell JW. Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med. 2015;13:554–61.
25.
26.
Sinko L, Ghazal LV, Fauer A, Wheldon CW. It takes more than rainbows: Supporting sexual and gender minority patients with trauma-informed cancer care. Cancer. 2024;130:507–16.CrossRefPubMed
27.
Wheldon CW, Roberts MC, Boehmer U. Differences in coping with breast cancer between lesbian and heterosexual women: a life course perspective. J Women’s Heal. 2019;28:1023–30.CrossRef
28.
Boehmer U, Glickman M, Winter M, Clark MA. Breast cancer survivors of different sexual orientations: which factors explain survivors’ quality of life and adjustment? Ann Oncol. 2013;24:1622–30.CrossRefPubMed
29.
Fobair P, O’Hanlan K, Koopman C, Classen C, DiMiceli S, Drooker N, et al. Comparison of lesbian and heterosexual women’s response to newly diagnosed breast cancer. Psychooncology. 2001;10:40–51.CrossRefPubMed
30.
Kiemen A, Czornik M, Weis J. How effective is peer-to-peer support in cancer patients and survivors? A systematic review. J Cancer Res Clin Oncol. 2023;149:9461–85.
31.
Kia H, MacKinnon KR, Abramovich A, Bonato S. Peer support as a protective factor against suicide in trans populations: a scoping review. Soc Sci Med. 2021;279:114026.CrossRefPubMed
32.
Clifford GM, Georges D, Shiels MS, Engels EA, Albuquerque A, Poynten IM, et al. A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale. Int J Cancer. 2021;148:38–47.CrossRefPubMed
33.
Leppard S. Anal cancer is on the rise; it’s a shame …. Aust Fam Physician. 2016;45:252–3.
34.
35.
36.
Thomas C, Wootten A, Robinson P. The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group. Eur J Cancer. 2013;22:522–9.CrossRef
37.
Dickstein DR, Edwards CR, Lehrer EJ, Tarras ES, Gallitto M, Sfakianos J, et al. Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer. Nat Rev Urol. 2023;20:332–55.
38.
Yuan R, Zhang C, Li Q, Ji M, He N. The impact of marital status on stage at diagnosis and survival of female patients with breast and gynecologic cancers: a meta-analysis. Gynecol Oncol. 2021;162:778–87.CrossRefPubMed
39.
Leone AG, Trapani D, Schabath MB, Safer JD, Scout NFN, Lambertini M, et al. Cancer in transgender and gender-diverse persons: a review. JAMA Oncol. 2023;9:556–63.CrossRefPubMed
40.
Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review. Cancer. 2019;125:4371–9.
41.
Franco-Rocha OY, Lewis KA, Kesler SR, Henneghan AM. An exploratory analysis of contributors to cognitive functioning among sexual and gender minority individuals who had COVID-19. J Homosex. 2024;1–16.
42.
Libert Y, Dubruille S, Borghgraef C, Etienne A-M, Merckaert I, Paesmans M, et al. Vulnerabilities in older patients when cancer treatment is initiated: does a cognitive impairment impact the two-year survival? PLoS ONE. 2016;11:e0159734.CrossRefPubMedPubMedCentral
43.
De Rosa N, Della Corte L, Giannattasio A, Giampaolino P, Di Carlo C, Bifulco G. Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study. Arch Gynecol Obstet. 2021;303:1581–8.
44.
Von Ah D, Storey S, Tallman E, Nielsen A, Johns S, Pressler S. Cancer, cognitive impairment, and work-related outcomes: an integrative review. Oncol Nurs Forum. 2016;43:602–16.CrossRef
Metadata
Title
The psychosocial health of sexual and gender minority people with anal and colorectal cancer: a mixed methods study
Authors
Oscar Y. Franco-Rocha
Katie Trainum
Christopher W. Wheldon
Publication date
08-05-2024
Publisher
Springer US
Published in
Journal of Cancer Survivorship
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-024-01611-5
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits